XCHO stock performance?

Xenacare Holdings Inc. (XCHO) news stock charts

Xenacare Holdings Inc. (XCHO/XCHO.OB) Investment Summary:

XenaCare Holdings, Inc. engages in the formulation, marketing, and distribution of nutrition supplement products primarily in the United States. Its clinical products include XenaCor, which lowers serum cholesterol, C-reactive protein, and homocysteine levels designed to support cardiovascular health; XenaTri for lowering triglycerides and raising HDL to support cardiovascular health; and XenaZyme Plus that increases the body’s oxygen carrying capacities designed to support digestion. XenaCare’s clinical products also comprise body replenishment products. In addition, the company offers formulations for the lifestyle performance market, which consists of sports line for athletes, including S...
www.xenacare.com
3 Employees
Founded in 2001

XENACARE HOLDINGS INC (XCHO:OTC Bulletin Board Market)

LAST $0.45 USD
CHANGE TODAY 0.00 0.00%
VOLUME 176.6K
As of 8:10 PM 03/19/10 All times are local (Market data is delayed by at least 15 minutes).

Snapshot of XENACARE HOLDINGS INC (XCHO)

OPEN
$0.44
PREVIOUS CLOSE
$0.45
DAY HIGH
$0.46
DAY LOW
$0.41
52 WEEK HIGH
02/16/10 - $0.55
52 WEEK LOW
08/5/09 - $0.01
MARKET CAP
29.6M
AVERAGE VOLUME 10 D
174.9K
EPS TTM
$-0.06
SHARES OUTSTANDING
65.7M
XCHO Does Not Pay Dividends
P/E TTM
--
K = Thousands  M = Millions  B = Billions

Key developments for XENACARE HOLDINGS INC (XCHO)

Xenacare Holdings Inc.'s Cobroxin to Be Available for Purchase in Walgreens by May 1, 2010

Xenacare Holdings Inc. announced that its over-the-counter (OTC) pain reliever, Cobroxin, will be available for purchase in Walgreens by May 1, 2010. Walgreens is considered one of the nation's largest pharmacy chains with 7,162 drugstores located throughout the United States. Cobroxin is the first over-the-counter (OTC) pain reliever clinically proven to treat moderate to severe (Stage 2) chronic pain. Many other Stage 2 drugs require prescriptions, including Tylenol 3, Percocet, and Vicodin. Cobroxin is currently available as an Advanced Oral Spray for treating migraine headaches, neck aches, shoulder pain, cramps, lower back pain, and neuralgia and is also available as an Advanced Topical Gel for treating joint pain and pain associated with repetitive stress and arthritis. Additional benefits to Cobroxin include: All Natural; Non-Addictive; Non-Narcotic; Non-Opiate; Long Lasting.

XenaCare Holdings, Inc Announces Availability of Cobroxin Advanced Topical Gel At Duane Reade

XenaCare Holdings Inc. announced that its award winning over-the-counter (OTC) pain reliever, Cobroxin Advanced Topical Gel, is now available at Duane Reade drugstores located throughout metropolitan New York. Duane Reade currently operates 253 stores in Manhattan. Cobroxin is the first over-the-counter (OTC) pain reliever clinically proven to treat moderate to severe (Stage 2) chronic pain. Many other Stage 2 drugs require prescriptions, including Tylenol 3, Percocet, and Vicodin. Cobroxin is currently available as an Advanced Oral Spray for treating migraine headaches, neck aches, shoulder pain, cramps, lower back pain, and neuralgia and is also available as an Advanced Topical Gel for treating joint pain and pain associated with repetitive stress and arthritis.

Xenacare Holdings Inc.s Cobroxin Now Available at Hannaford and Sweetbay Supermarkets

XenaCare Holdings Inc. announced that its over-the-counter pain reliever, Cobroxin, is now available at Hannaford and Sweetbay Supermarkets. Cobroxin is the first over-the-counter pain reliever clinically proven to treat moderate to severe (Stage 2) chronic pain. Many other Stage 2 drugs require prescriptions, including Tylenol 3, Percocet, and Vicodin. Cobroxin is currently available as an oral spray for treating migraine headaches, neck aches, shoulder pain, cramps, lower back pain, and neuralgia and is also available as a topical gel for treating joint pain and pain associated with repetitive stress and arthritis. Additional benefits to Cobroxin include: all natural; non-addictive; non-narcotic; non-opiate; and long lasting.

Xenacare Holdings Inc. financial resources

otc, otcbb, pinksheet, XCHO, ob Xenacare Holdings Inc.

XCHO Competitors

Company Last Change
No competitor information is available for XCHO.
Market data is delayed at least 15 minutes.
 

Industry Analysis

Valuation XCHO Industry Range
Price/Earnings NM Not Meaningful
Price/Sales NM Not Meaningful
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful

XCHO

XCHO transactions

Type
Date
Target
No transactions in the last 6 months.

More Recent Financial News About Xenacare Holdings Inc.

XenaCare Holdings Announces Changes to Cobroxin Advertising Campaign and Signing of Professional Athletic Sponsorship

Quote: The change inadvertising occurred due to unforeseen timing circumstances withProfessional Sports Publications, the publisher of the NCAA gamedayprograms.National Collegiate Athletic AssociationCobroxinNew York MetsLos Angeles DodgersChicago Cubs, and represents approximately seven times the viewership ofthat of the NCAA advertising campaign.Beijing OlympicsSpikeKey.comMagazine.XenaCareHoldings. “We look forward to working closely with Megan as wecontinue to expand our national advertising ...
Read article

Cobroxin Now Available at Hannaford and Sweetbay Supermarkets

Quote: Sweetbay Supermarkets currently operates 104 stores throughout Florida.“Both Hannaford and Sweetbay Supermarkets are brands synonymous with high-quality products and great value,” explained Frank Rizzo, CEO of XenaCare Holdings. “We are excited to be working with two of the premier regional food retailers to introduce Cobroxin to those living in the northeastern United States and in Florida,” he added.Cobroxin is the first over-the-counter (OTC) pain reliever clinically p...
Read article

Over-the-Counter (OTC) Pain Reliever, Cobroxin, to be Sold in Walgreens

Quote: Walgreens isconsidered one of the nation’s largest pharmacy chains with 7,162drugstores located throughout the United States.XenaCareHoldings. “We look forward to working closely with Walgreens aswe prepare for this launch and finalize our promotional strategy tosupport ongoing sales efforts by the retailer,” he added.CobroxinAdvancedOral SprayAdvancedTopical Gel for treating joint pain and pain associated withrepetitive stress and arthritis.Additional benefits to Cobroxin inc...
Read article

Over-the-Counter (OTC) Pain Reliever, Cobroxin, to be Sold in Walgreens

Quote: Walgreens isconsidered one of the nation’s largest pharmacy chains with 7,162drugstores located throughout the United States.XenaCareHoldings. “We look forward to working closely with Walgreens aswe prepare for this launch and finalize our promotional strategy tosupport ongoing sales efforts by the retailer,” he added.CobroxinAdvancedOral SprayAdvancedTopical Gel for treating joint pain and pain associated withrepetitive stress and arthritis.Additional benefits to Cobroxin inc...
Read article

XenaCare Holdings Announces Changes to Cobroxin Advertising Campaign and Signing of Professional Athletic Sponsorship

Quote: The change inadvertising occurred due to unforeseen timing circumstances withProfessional Sports Publications, the publisher of the NCAA gamedayprograms.National Collegiate Athletic AssociationCobroxinNew York MetsLos Angeles DodgersChicago Cubs, and represents approximately seven times the viewership ofthat of the NCAA advertising campaign.Beijing OlympicsSpikeKey.comMagazine.XenaCareHoldings. “We look forward to working closely with Megan as wecontinue to expand our national advertising ...
Read article

Cobroxin Advanced Topical Gel Now Available at Duane Reade

Quote: Duane Readecurrently operates 253 stores in Manhattan.“Duane Reade is considered one of the premier and fastest growing retailpharmacies in the United States and consistently ranks top in theindustry for productivity, as measured by sales per square foot,”explained Frank RizzoXenaCareHoldingsCobroxinAdvanced Topical Gel to those suffering from moderate to severechronic pain,” he added.Cobroxinis the first over-the-counter (OTC) pain reliever clinically proven totreat moderate t...
Read article

XenaCare Holdings Announces Upcoming Cobroxin Advertising in the NCAA March Madness Tournament Program

Quote: Inaddition to publishing the NCAA Official Tournament Program, PSPworks with over 100 professional sports franchises throughout the fourmajor sports, as well as numerous universities coast to coast.“The NCAA March Madness Tournament is one of the most popular sportstournaments in North America with an average of 24.6 million householdswatching at least a portion of the games,” explained Frank RizzoXenaCareHoldingsCobroxin.We look forward to working closely with Professional Sports Pu...
Read article

Cobroxin Now Available at Hannaford and Sweetbay Supermarkets

Quote: Hannaford Supermarkets is one of the largest foodretailers in the northeastern United States, operating 171 storesthroughout Maine, Massachusetts, New Hampshire, New York, and Vermont.Sweetbay Supermarkets currently operates 104 stores throughout Florida.“Both Hannaford and Sweetbay Supermarkets are brands synonymous withhigh-quality products and great value,” explained Frank Rizzo, CEO ofXenaCare Holdings. “We are excited to be working with two of the premierregional food reta...
Read article

XENACARE HOLDINGS, INC. Files SEC form 8-K, Change in Directors or Principal Officers

Quote: Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Effective March 6, 2009, the board of directors of XenaCare Holdings, Inc. (the "Registrant" or the "Company") increased the number of seats on the Company's board of directors from four to five and appointed Rik Deitsch to fill the vacancy created by the additional seat. Mr. Deitsch shall serve as a director until the...
Read article

XenaCare Holdings Announces Agreement to Market its Over-the-Counter Pain Reliever, Cobroxin, in the Official Annual Publication of NASCAR

Quote: In addition to reaching approximately 8.5 million NASCAR fansattending the 78 NASCAR events being held at the 26 NASCAR sanctionedracetracks, the Publication will also be sold throughout North Americain major newsstands, bookstores, grocery stores, retail outlets, trainstations, and airports.Cobroxinin the 2010 Racing One Annual, as it offers us the opportunity tobuild awareness around Cobroxin by introducing it through NASCAR,the fastest growing spectator sport in the United States,” c...
Read article

XenaCare Holdings Announces Agreement to Market OTC Pain Reliever, Cobroxin, in the National Football League (NFL) Alumni Association Publication

Quote: In addition to its public release, the2009 Publication will also be released under a controlled distributionto current and past players of the league, team owners, coaches,and league executives.“We are excited to announce this advertising agreement because the NFLAlumni Association not only represents one of the most prestigioussports organizations in North AmericaCobroxin,”explained Frank Rizzo, President of XenaCare Holdings. “Aswe move forward with our national launch, we pl...
Read article

XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation

Quote: XCHONews), a company specializing in themarketing and retail distribution of consumer healthcare products,has announced today that is has become a national sponsor of the ArthritisFoundation at the National Proud Sponsor level.“As one of the largest and most well-respected nonprofit organizationsdedicated to arthritis research and public health education,the Arthritis Foundation is on an important mission to improvethe quality of life for millions of people around the world sufferingfrom m...
Read article

XenaCare Holdings Announces Availability of Cobroxin through the Chain Drug Marketing Association (CDMA)

Quote: The CDMA currentlyhas over 6,000 independent pharmacy members throughout the UnitedStates.“As one of the largest pharmacy organizations in the United States, weare excited to be working with the CDMACobroxinto its independent pharmacy members,” explained Frank Rizzo, Presidentof XenaCare Holdings. “Having a presence in CDMA memberpharmacies will help us build significant awareness about Cobroxinas we continue to expand the brand nationwide through retailers and ourmultimillion ...
Read article

XENACARE HOLDINGS, INC. Files SEC form 10-Q, Quarterly Report

Quote: MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIONS AND RESULTS OF OPERATIONS Introduction Management's discussion and analysis of financial condition and results of operations is provided as a supplement to our condensed consolidated financial statements and accompanying notes to help provide an understanding of our financial condition, changes in financial condition and results of operations. The discussion and analysis is organized as follows: Terms and Definitions Company "...
Read article

XENACARE HOLDINGS, INC. Files SEC form 10-Q, Quarterly Report

Quote: MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIONS AND RESULTS OF OPERATIONS Introduction Management's discussion and analysis of financial condition and results of operations is provided as a supplement to our condensed consolidated financial statements and accompanying notes to help provide an understanding of our financial condition, changes in financial condition and results of operations. The discussion and analysis is organized as follows: Terms and Definitions Company "...
Read article

Nutra Pharma Announces Online Availability of Cobroxin for the Treatment of Moderate to Severe Chronic Pain

Quote: DeitschNutraPharma CorporationCobroxin.com.We plan to announce our online retail partnerships in the next coupleweeks and to continue to update our shareholders about ourbrick-and-mortar retail partnerships as Cobroxin rolls-outacross the United States,” he concluded.NutraPharma announced that it had granted XenaCare HoldingsXCHONewsCobroxinthroughout the United States. XenaCare Holdings has planned its initialprint marketing campaign for Cobroxin to begin this fall thatincludes advertisin...
Read article

Nutra Pharma Announces Plans to Begin Drug Registration Process in Canada and Europe for its Over-the-Counter Pain Reliever

Quote: Additionally, the company recently completed a licensingagreement that grants XenaCare HoldingsXCHONews) theexclusive marketing and distribution rights to Cobroxin withinthe United States.About Nutra Pharma Corp.Nutra Pharma Corp. is a biopharmaceutical company specializing in theacquisition, licensing and commercialization of pharmaceutical productsand technologies for the management of neurological disorders, cancer,autoimmune and infectious diseases. Nutra Pharma Corp. through itssubsidiaries...
Read article

XENACARE HOLDINGS, INC. Files SEC form 10-Q/A, Quarterly Report

Quote: MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIONS AND RESULTS OF OPERATIONS Introduction Management's discussion and analysis of financial condition and results of operations is provided as a supplement to our condensed consolidated financial statements and accompanying notes to help provide an understanding of our financial condition, changes in financial condition and results of operations. The discussion and analysis is organized as follows: Terms and Definitions Company "...
Read article

Nutra Pharma Announces Manufacturing Release of Cobroxin, a Treatment for Chronic Pain

Quote: “Because this process was completed earlyand we have already signed off for final distribution to XenaCareHoldings, we anticipate that Cobroxinth,” he added.Cobroxinis the first OTC pain reliever clinically proven to treatStage 2 (moderate to severe) chronic painReceptoPharm,will be available as an oral spray for treating lower back pain,migraines, neck aches, shoulder pain, crampsand neuralgia and as a topical gel for treating jointpain and pain associated with repetitive stress and...
Read article

XENACARE HOLDINGS, INC. Files SEC form 10-Q, Quarterly Report

Quote: MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIONS AND RESULTS OF OPERATIONS Introduction Management's discussion and analysis of financial condition and results of operations is provided as a supplement to our condensed consolidated financial statements and accompanying notes to help provide an understanding of our financial condition, changes in financial condition and results of operations. The discussion and analysis is organized as follows: Terms and Definitions Company "...
Read article

Would you like to leave a comment about Xenacare Holdings Inc. XCHO/XCHO.OB

Besides Xenacare Holdings Inc.'s Stock there is more great penny stock and market information at Realpennies